125 related articles for article (PubMed ID: 11152559)
1. Genotoxicity of 3-methylcholanthrene in liver of transgenic big Blue mice.
Rihn BH; Bottin MC; Coulais C; Rouget R; Monhoven N; Baranowski W; Edorh A; Keith G
Environ Mol Mutagen; 2000; 36(4):266-73. PubMed ID: 11152559
[TBL] [Abstract][Full Text] [Related]
2. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
4. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
[TBL] [Abstract][Full Text] [Related]
5. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
6. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
Shane BS; Lockhart AM; Winston GW; Tindall KR
Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
[TBL] [Abstract][Full Text] [Related]
7. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
8. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice.
Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML
Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone.
Autrup H; Jørgensen EC; Jensen O
Mutagenesis; 1996 Jan; 11(1):69-73. PubMed ID: 8671718
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the liver, colon and kidney of Big Blue rats treated with 2-amino-3-methylimidazo[4,5-f]quinoline.
Bol SA; Horlbeck J; Markovic J; de Boer JG; Turesky RJ; Constable A
Carcinogenesis; 2000 Jan; 21(1):1-6. PubMed ID: 10607726
[TBL] [Abstract][Full Text] [Related]
11. A more efficient Big Blue protocol improves transgene rescue and accuracy in a adduct and mutation measurement.
Bielas JH
Mutat Res; 2002 Jul; 518(2):107-12. PubMed ID: 12113761
[TBL] [Abstract][Full Text] [Related]
12. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
13. LacI mutation spectra following benzo[a]pyrene treatment of Big Blue mice.
Shane BS; de Boer J; Watson DE; Haseman JK; Glickman BW; Tindall KR
Carcinogenesis; 2000 Apr; 21(4):715-25. PubMed ID: 10753208
[TBL] [Abstract][Full Text] [Related]
14. Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver.
Ross JA; Leavitt SA
Mutagenesis; 1998 Mar; 13(2):173-9. PubMed ID: 9568591
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hprt and lacI mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene-treated Big Blue rats.
Chen T; Mittelstaedt RA; Aidoo A; Hamilton LP; Beland FA; Casciano DA; Heflich RH
Environ Mol Mutagen; 2001; 37(3):195-202. PubMed ID: 11317337
[TBL] [Abstract][Full Text] [Related]
16. Subchronic administration of phenobarbital alters the mutation spectrum of lacI in the livers of Big Blue transgenic mice.
Shane BS; Smith-Dunn DL; deBoer JG; Glickman BW; Cunningham ML
Mutat Res; 2000 Mar; 448(1):69-80. PubMed ID: 10751624
[TBL] [Abstract][Full Text] [Related]
17. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
You YH; Halangoda A; Buettner V; Hill K; Sommer S; Pfeifer G
Mutat Res; 1998 Dec; 420(1-3):55-65. PubMed ID: 9838042
[TBL] [Abstract][Full Text] [Related]
18. Induction of lacI mutations in Big Blue Rat-2 cells treated with 1-(2-hydroxyethyl)-1-nitrosourea: a model system for the analysis of mutagenic potential of the hydroxyethyl adducts produced by 1,3-bis (2-chloroethyl)-1-nitrosourea.
Sprung CN; Wang YP; Miller DL; Giannini DD; Dhananjaya N; Bodell WJ
Mutat Res; 2001 Dec; 484(1-2):77-86. PubMed ID: 11733074
[TBL] [Abstract][Full Text] [Related]
19. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice.
Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T
Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063
[TBL] [Abstract][Full Text] [Related]
20. In vivo genotoxicity of 2-amino-3,8-dimethylimidazo[4, 5-f]quinoxaline in lacI transgenic (Big Blue) mice.
Itoh T; Suzuki T; Nishikawa A; Furukawa F; Takahashi M; Xue W; Sofuni T; Hayashi M
Mutat Res; 2000 Jun; 468(1):19-25. PubMed ID: 10863154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
